Last updated on September 2018

8-Week Atopic Dermatitis (AD) Treatment Study


Brief description of study

This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).

Detailed Study Description

This will be a 9-week, randomized, double blind, parallel comparison study consisting of a 1-week washout phase followed by an 8-week treatment phase. This study will be executed by one clinical research company utilizing two test sites and up to 62 subjects with moderate or severe atopic dermatitis, ages 12-65, will be enrolled. Subjects that are enrolled will be placed on one of three products (e.g. Sponsor's Experimental Cream Treatment, a basic moisturizer, or a positive control - Desonide) and will be required to use the assigned product twice a day for the duration of the 8-week treatment phase.

Clinical Study Identifier: NCT03386032

Contact Investigators or Research Sites near you

Start Over

Adnan Nasir, MD, Ph.D,

Wake Research, LLC
Raleigh, NC United States

Richard A Krause, MD

WR (Wake Research) ClinSearch
Chattanooga, TN United States